Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

C4 Therapeutics, Inc. CCCC

Set alert

Price alert · CCCC

All alert types
3.21 USD -0.16 -4.75%

At close · Nov 2

3.21 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
3.20 × 2
Ask
3.21 × 2
3.16 Day range 3.41
1.69 52-week range 5.17
YTD
+68.06%
1 year
+22.99%
Open
3.36
Prev close
3.37
Mkt cap
394.91M
Vol
2.86M
Avg vol
2.43M
EPS
-0.91
P/E
0.00
Div yield
0.00%
More statistics
Low
3.16
High
3.41
Forward P/E
-2.37
Beta
3.06
Short ratio
7.10
Inst. own
91.47%
Dividend
0.00
Ex-div date
Earnings
Aug 1, 2024
50-d avg
5.06
200-d avg
5.96
1y target
15.00

3M chart

Chart tools
Interval
1m5m15m30m

Signals (18)
NameDateAgo
SMA: BearishNov 2, 20268 hours ago
SMA: BullishOct 30, 20263 days ago
SMA: BearishOct 29, 20264 days ago
SMA: BullishOct 28, 20265 days ago
SMA: BullishOct 27, 20266 days ago
SMA: BearishOct 23, 20261 week ago
SMA: BullishOct 20, 20261 week ago
MACD: Buy SignalOct 19, 20262 weeks ago
MACD: Sell SignalOct 14, 20262 weeks ago
MACD: Buy SignalOct 9, 20263 weeks ago
RSI: OversoldSep 23, 20261 month ago
SMA: BearishSep 2, 20262 months ago
SMA: BullishSep 1, 20262 months ago
SMA: BearishAug 31, 20262 months ago
SMA: BearishAug 28, 20262 months ago
MACD: Sell SignalAug 28, 20262 months ago
SMA: BullishAug 11, 20262 months ago
MACD: Buy SignalAug 6, 20262 months ago

Financial health

Altman Z-Score

-1.03 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 3

Valuation

P/E -1.5×
FY 2018: -24.0×FY 2019: -32.3×FY 2020: -21.5×FY 2021: -17.7×FY 2022: -2.3×FY 2023: -2.1×FY 2024: -2.4×FY 2025: -1.5×
FY 2018 5y median -2.3× FY 2025
P/S 4.4×
FY 2018: 19.5×FY 2019: 51.2×FY 2020: 43.0×FY 2021: 32.4×FY 2022: 9.3×FY 2023: 13.5×FY 2024: 7.0×FY 2025: 4.4×
FY 2018 5y median 9.3× FY 2025
P/B 0.6×
FY 2018: -4.7×FY 2019: -9.8×FY 2020: 5.1×FY 2021: 3.8×FY 2022: 1.0×FY 2023: 1.1×FY 2024: 1.2×FY 2025: 0.6×
FY 2018 5y median 1.1× FY 2025
P/FCF -1.6×
FY 2018: -19.2×FY 2019: 20.2×FY 2020: -21.0×FY 2021: -16.8×FY 2022: -2.6×FY 2023: -2.6×FY 2024: -3.8×FY 2025: -1.6×
FY 2018 5y median -2.6× FY 2025
EV/EBITDA -1.4×
FY 2018: -23.5×FY 2019: -32.1×FY 2020: -21.5×FY 2021: -18.1×FY 2022: -2.8×FY 2023: -1.8×FY 2024: -2.5×FY 2025: -1.4×
FY 2018 5y median -2.5× FY 2025
EV/Sales 4.0×
FY 2018: 18.3×FY 2019: 47.7×FY 2020: 38.2×FY 2021: 31.7×FY 2022: 11.1×FY 2023: 10.8×FY 2024: 7.3×FY 2025: 4.0×
FY 2018 5y median 10.8× FY 2025
FCF Yield -62.7%
FY 2018: -5.2%FY 2019: 5.0%FY 2020: -4.8%FY 2021: -6.0%FY 2022: -38.7%FY 2023: -38.7%FY 2024: -26.2%FY 2025: -62.7%
FY 2018 5y median -38.7% FY 2025

Profitability

Gross Margin 77.8%
FY 2018: -47.7%FY 2019: 100.0%FY 2020: -136.3%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 62.7%FY 2024: 100.0%FY 2025: 77.8%
FY 2018 5y median 100.0% FY 2025
Operating Margin -290.7%
FY 2018: -84.6%FY 2019: -165.8%FY 2020: -182.1%FY 2021: -179.4%FY 2022: -416.6%FY 2023: -669.8%FY 2024: -336.1%FY 2025: -290.7%
FY 2018 5y median -336.1% FY 2025
Net Margin -292.1%
FY 2018: -81.1%FY 2019: -159.5%FY 2020: -199.8%FY 2021: -183.2%FY 2022: -412.2%FY 2023: -638.3%FY 2024: -296.0%FY 2025: -292.1%
FY 2018 5y median -296.0% FY 2025
ROE -40.9%
FY 2018: 19.7%FY 2019: 30.5%FY 2020: -23.6%FY 2021: -21.5%FY 2022: -44.3%FY 2023: -53.8%FY 2024: -48.8%FY 2025: -40.9%
FY 2018 5y median -44.3% FY 2025
ROIC -31.4%
FY 2018: -13.3%FY 2019: -41.5%FY 2020: -16.9%FY 2021: -18.0%FY 2022: -32.9%FY 2023: -41.0%FY 2024: -38.6%FY 2025: -31.4%
FY 2018 5y median -32.9% FY 2025
ROA -29.2%
FY 2018: -10.7%FY 2019: -28.8%FY 2020: -16.6%FY 2021: -16.6%FY 2022: -29.8%FY 2023: -35.2%FY 2024: -30.1%FY 2025: -29.2%
FY 2018 5y median -29.8% FY 2025

Growth (YoY)

Revenue 1.0%
FY 2018: 0.0%FY 2019: 10.4%FY 2020: 55.3%FY 2021: 37.9%FY 2022: -32.1%FY 2023: -33.3%FY 2024: 71.4%FY 2025: 1.0%
FY 2018 FY 2025
Operating Income 12.6%
FY 2018: 0.0%FY 2019: -116.3%FY 2020: -70.5%FY 2021: -35.9%FY 2022: -57.7%FY 2023: -7.3%FY 2024: 14.0%FY 2025: 12.6%
FY 2018 FY 2025
EPS (diluted) 16.4%
FY 2018: 0.0%FY 2019: 25.5%FY 2020: -94.9%FY 2021: -18.2%FY 2022: -44.0%FY 2023: -1.9%FY 2024: 43.1%FY 2025: 16.4%
FY 2018 FY 2025
Free Cash Flow -52.0%
FY 2018: 0.0%FY 2019: 375.9%FY 2020: -225.1%FY 2021: -30.0%FY 2022: -26.3%FY 2023: 2.6%FY 2024: 39.8%FY 2025: -52.0%
FY 2018 FY 2025

Financial Health

Current Ratio 7.8×
FY 2018: 5.2×FY 2019: 2.9×FY 2020: 8.7×FY 2021: 6.4×FY 2022: 6.5×FY 2023: 6.3×FY 2024: 5.7×FY 2025: 7.8×
FY 2018 5y median 6.4× FY 2025
Quick Ratio 7.8×
FY 2018: 5.2×FY 2019: 2.9×FY 2020: 8.7×FY 2021: 6.4×FY 2022: 7.8×FY 2023: 6.3×FY 2024: 5.7×FY 2025: 7.8×
FY 2018 5y median 6.4× FY 2025
Debt / Equity 0.2×
FY 2018: -0.2×FY 2019: -0.1×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.3×FY 2023: 0.3×FY 2024: 0.3×FY 2025: 0.2×
FY 2018 5y median 0.3× FY 2025
Net Debt / EBITDA 0.1×
FY 2018: 1.4×FY 2019: 2.4×FY 2020: 2.7×FY 2021: 0.4×FY 2022: -0.5×FY 2023: 0.4×FY 2024: -0.1×FY 2025: 0.1×
FY 2018 5y median 0.1× FY 2025
Interest Coverage 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: -49.2×FY 2021: -38.3×FY 2022: -58.5×FY 2023: -101×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median -38.3× FY 2025

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31